Analyst Luca Issi works at RBC and is covering the the Healthcare sector with 143 price targets and ratings documented since 2020 spanning on 18 stocks.
Luca Issi's average stock forecast success ratio is 26.22% with an average time for price targets to be met of 39.83 days.
Most recent stock forecast was given on ALNY, Alnylam Pharmaceuticals, Inc at 31-May-2023.
Analyst best performing recommendations are on ARWR (ARROWHEAD PHARMACEUTICALS, INC).
The best stock recommendation documented was for RGNX (REGENXBIO INC) at 5/13/2020. The price target of $42 was fulfilled within 8 days with a profit of $4.72 (12.66%) receiving and performance score of 15.83.
Average potential price target upside
Currently, out of the existing stock ratings of Luca Issi - 3 which are a Buy (37.5%), 5 which are a Hold (62.5%)
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Buy
15
$9.43 (169.30%)
19
1 days ago
2/7 (28.57%)
$11.18 (121.55%)
106
Buy
15
$9.43 (169.30%)
18
3 months 5 days ago
0/7 (0%)
$15.25 (121.96%)
Buy
20
$14.43 (259.07%)
31
3 months 5 days ago
2/8 (25%)
$10.13 (83.14%)
93
Buy
32
3 months 5 days ago
3/5 (60%)
$8.07 (50.72%)
43
Buy
12
$6.43 (115.44%)
11
5 months ago
1/2 (50%)
$4.3 (64.63%)
18
